Search results for: 'Preferred Destination for Clinical Trials 2020'

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

The global decentralized clinical trial (DCT) market has been witnessing a continued surge after the COVID-19 pandemic. The accelerated DCT adoption in 2020 was driven by restricted mobility of site investigators, clinical research associates, and patients to participate in trials, which resulted in a significant halt in trial activities worldwide....

17 May 2018  |  North America  |  Market Research

Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020

Wearables and Mobile Technologies Growth Opportunities in Digital Transformation Journey of Clinical Trials

Infographics

×

Key Issues Addressed

Clinical trial sponsors and clinical research organizations (CROs) are facing intense pressure to change the way clinical research is conducted and justify the costs and time involved in the clinical development process. Some of the prevailing challenges in the clinical trial industry include the complexity and cost of conducting clinical trials, t...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

This Frost Radar™ investigates the growth and innovation activity of clinical decision support system (CDSS) providers in their pursuit to help end users take the next best medical care action. A CDSS provides professionals with access to organized clinical knowledge integrated with the patient’s medical profile to improve their health and overall ...

The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...

06 Jul 2021  |  North America  |  Market Research

Global Decentralized Clinical Trial (DCT) Growth Opportunities

Strategic Partnering and M&A Activity in At-home Monitoring Solutions Gain Momentum

Infographics

×

Frost & Sullivan presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the markets maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations (CR...

COVID-19 has accelerated the need for a faster, more accessible clinical trial process. During the height of the pandemic, in-person follow-ups for ongoing trials were replaced with hand-held devices that essentially built an ecosystem for home health care support services that can be easily leveraged to avoid or reduce participant dropout rates. ...

19 Sep 2023  |  North America  |  Market Research

Growth Opportunities for Clinical Laboratory Services in Asia-Pacific

Proliferation of High-end Specialized Testing and Interconnected Lab Networks Fuel Growth Potential

Infographics

×

Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022–2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding f...